Outpatient CD28-costimulated CAR T-cells for B-cell malignancies with CNS involvement

被引:1
|
作者
Sanber, Khaled [1 ]
Ly, Andrew [2 ]
Ondo, Angela [1 ]
Mooney, Kathy [1 ]
Baker, Julie [1 ]
Shedeck, Audra [1 ]
Wagner-Johnston, Nina [1 ]
Jain, Tania [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Bone Marrow Transplanta, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] 1650 Orleans St, 3M 88, Baltimore, MD 21287 USA
关键词
NERVOUS-SYSTEM LYMPHOMA;
D O I
10.1002/ajh.27051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E301 / E304
页数:4
相关论文
共 50 条
  • [1] CD28-COSTIMULATED CD19 CAR T CELLS FOR PEDIATRIC RELAPSED AND REFRACTORY MATURE B-CELL LYMPHOMA
    Jacoby, Elad
    Adam, Etai
    Abramovich, Alon
    Shapira, Adi
    Hutt, Daphna
    Itzhaki, Orit
    Bielorai, Bella
    Toren, Amos
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 563 - 564
  • [2] Bispecific CAR T-cells for B-cell Malignancies
    Furqan, Fateeha
    Shah, Nirav N.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (08) : 1005 - 1015
  • [3] Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies
    Shalabi, Haneen
    Martin, Staci
    Yates, Bonnie
    Wolters, Pamela L.
    Kaplan, Claire
    Smith, Hannah
    Sesi, Christopher R.
    Jess, Jennifer
    Toledo-Tamula, Mary Ann
    Struemph, Kari
    Delbrook, Cindy P.
    Khan, Omar, I
    Mackall, Crystal L.
    Lee, Daniel W.
    Shah, Nirali N.
    NEURO-ONCOLOGY, 2022, 24 (09) : 1584 - 1597
  • [4] SUV39H1 disruption imparts functional persistence to CD28-costimulated human CAR T cells
    Jain, Nayan
    Zhao, Zeguo
    Koche, Richard
    Gozlan, Yosi
    Brocks, David
    Raveh-Sadka, Tali
    Wells, Danny
    Dobrin, Anton
    Shi, Yuzhe
    Lopez, Michael
    Gunset, Gertrude
    Sadelain, Michel
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [5] Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
    Guedan, Sonia
    Madar, Aviv
    Casado-Medrano, Victoria
    Shaw, Carolyn
    Wing, Anna
    Liu, Fang
    Young, Regina M.
    June, Carl H.
    Posey, Avery D., Jr.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 3087 - 3097
  • [6] T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy
    Heijink, D. M.
    Kater, A. P.
    Hazenberg, M. D.
    Hagenbeek, A.
    Kersten, M. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2016, 74 (04): : 147 - 151
  • [7] CD28 CAR T Cells for the Treatment of T Cell Malignancies
    Willier, Semjon
    Farber, Julian
    Ispyrlidou, Theodora
    Stenger, Dana
    Nikolaides, Sophia L. M.
    Ernst, Paulina Ferrada
    Peters, Annika E.
    Wilhelm, Jonas
    Stoll, Nadine
    Breidenbach, Maike
    Becker-Dettling, Fiona Ag
    Blaeschke, Franziska
    Kaeuferle, Theresa
    Yassin, Abdallah A. H. A.
    Klein, Christoph
    Feuchtinger, Tobias
    BLOOD, 2023, 142
  • [8] CAR engineered umbilical cord blood T-cells as a targeted treatments for B-cell malignancies
    Georgiadis, C.
    Preece, R.
    Saudemont, A.
    Alsubki, R.
    Abramowski-Mock, U.
    Bor, L.
    Zhan, H.
    Qasim, W.
    HUMAN GENE THERAPY, 2016, 27 (11) : A84 - A85
  • [9] CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies
    Martyniszyn, Alexandra
    Krahl, Ann-Christin
    Andre, Maya C.
    Hombach, Andreas A.
    Abken, Hinrich
    HUMAN GENE THERAPY, 2017, 28 (12) : 1147 - 1157
  • [10] Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia
    Schuster, Stephen J.
    Hosing, Chitra M.
    Shpall, Elizabeth J.
    Levine, Bruce L.
    Aqui, Nicole A.
    Chong, Elise A.
    Svoboda, Jakub
    Gordon, Amanda
    McMannis, John D.
    Bosque, Doyle
    Cotte, Julio
    Brennan, Andrea L.
    Zheng, Zhaohui
    Leinbach, Leah
    Xu, YinYan
    Veloso, Elizabeth
    Decker, William
    Bollard, Catherine M.
    Keating, Michael J.
    June, Carl H.
    BLOOD, 2011, 118 (21) : 1231 - 1232